Showing results (681-690 of 896) with videos related to

Sort By:
Pageof 90
Clinical Endocrinology|April 18, 2003
Oral administration of the growth hormone secretagogue NN703 in adult patients with growth hormone deficiencyJ Svensson, J P Monson, T Vetter, et al.
BJU International|July 12, 2019
Guideline adherence for the surgical treatment of T1 renal tumours correlates with hospital volume: an analysis from the British Association of Urological Surgeons Nephrectomy AuditMaxine G B Tran, Katja K H Aben, Erik Werkhoven, et al.
Nature Reviews. Urology|June 16, 2018
An interdisciplinary consensus on the management of bone metastases from renal cell carcinomaViktor Grünwald, Berit Eberhardt, Axel Bex, et al.
Kidney International|November 10, 2021
Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathyAlexandra Cambier, Patrick J Gleeson, Lilia Abbad, et al.
The Journal of Urology|June 24, 2018
Intraoperative Cyst Rupture during Partial Nephrectomy for Cystic Renal Masses-Does it Increase the Risk of Recurrence?Benjamin Pradere, Benoit Peyronnet, Gauthier Delporte, et al.
Insights Into Imaging|May 22, 2019
Cryoablation and immunotherapy: an overview of evidence on its synergyB M Aarts, E G Klompenhouwer, S L Rice, et al.
Nederlands Tijdschrift Voor Geneeskunde|July 23, 2015
[Relationship between pre-dialysis period and mortality and morbidity; the importance of timely pre-dialysis care]S T Tom Laurens, C G T Kitty Bex, Loes Janssen, et al.
Urologia Internationalis|August 18, 2017
Endo-Urological Techniques for Benign Uretero-Ileal Strictures Have Poor Efficacy and Affect Renal FunctionElisabeth E Fransen van de Putte, Liesbeth L de Wall, Erik van Werkhoven, et al.
European Urology Oncology|April 10, 2025
Hospital Volume as a Determinant of Outcomes After Partial Nephrectomy: A Systematic Review by the European Association of Urology Renal Cell Carcinoma Guidelines PanelLorenzo Marconi, Teele Kuusk, Milan Hora, et al.
Cancer Treatment Reviews|June 22, 2011
Multidisciplinary management of metastatic renal cell carcinoma in the era of targeted therapiesBernard Escudier, Susanne Osanto, Börje Ljungberg, et al.
Pageof 90